ANI PHARMACEUTICALS INC — Investor Relations & Filings
Filings indexed
1,280
across all filing types
Latest filing
2026-05-21
Regulatory Filings
Country
US
United States of America
Listing
US
ANIP
ANI Pharmaceuticals, Inc. is a diversified biopharmaceutical company engaged in the development, manufacturing, and marketing of pharmaceutical products. Its portfolio includes high-quality branded and generic prescription drugs, as well as over-the-counter (OTC) medicines. The company serves patients across various therapeutic areas, with a presence in the rare disease market and a strategic focus on expanding its ophthalmology and retina franchise.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K | 2026-05-21 | English | |
| 8-K - ANI PHARMACEUTICALS INC (0001023024) (Filer) | 2026-05-13 | English | |
| 10-Q - ANI PHARMACEUTICALS INC (0001023024) (Filer) | 2026-05-08 | English | |
| 8-K - ANI PHARMACEUTICALS INC (0001023024) (Filer) | 2026-05-08 | English | |
| ARS - ANI PHARMACEUTICALS INC (0001023024) (Filer) | 2026-04-09 | English | |
| DEF 14A - ANI PHARMACEUTICALS INC (0001023024) (Filer) | 2026-04-09 | English |
Browse filings by year
17 yearsMarket data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Appili Therapeutics Inc.
Biopharmaceutical company developing novel medicines for in…
|
APLI | CA | Manufacturing |
|
Applied BioCode
Develops and manufactures high-throughput multiplex molecul…
|
6598 | TW | Manufacturing |
|
Applied Therapeutics, Inc.
Clinical-stage biopharma developing novel drugs for rare me…
|
APLT | US | Manufacturing |
|
Aprogen Biologics Inc.
Develops and manufactures novel biologics and biosimilar an…
|
003060 | KR | Manufacturing |
|
Aprogen, Inc
Develops and manufactures biologic medicines, including bio…
|
007460 | KR | Manufacturing |
|
Aptabio Therapeutics Inc.
Develops drugs for intractable diseases by regulating oxida…
|
293780 | KR | Manufacturing |
|
Aptamer Sciences Inc
Clinical-stage company developing aptamer-based therapeutic…
|
291650 | KR | Manufacturing |
|
Aptorum Group Ltd
Clinical-stage biopharma developing therapeutics for oncolo…
|
APM | US | Manufacturing |
|
Aptus Pharma Limited
Develops and manufactures cardiovascular, metabolic, and ga…
|
544529 | IN | Manufacturing |
|
Aquestive Therapeutics, Inc.
Pharmaceutical company developing oral film medicines for C…
|
AQST | US | Manufacturing |
ANI PHARMACEUTICALS INC via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/31676/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=31676 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=31676 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=31676 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 31676}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for ANI PHARMACEUTICALS INC (id: 31676)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.